Anticoagulation is a cornerstone of therapy for atrial fibrillation because it lowers the heightened risk for stroke in this population. People with chronic kidney disease are also at increased risk for stroke, but the benefits of anticoagulation are less clear in this group, and anticoagulation is used less often in AF patients who have CKD. Now, a large observational study offers some reassurance that anticoagulation in AF patients with CKD may be beneficial.
Researchers in Sweden analyzed data from more than 24,000 survivors of acute myocardial infarction who had AF….
…
Click here to read the full post on Forbes.
Speak Your Mind